Ad Hoc studies in under 60 minutes

Your experience in treating different types of pathologies helps improve patient care and the implementation of new treatments.

Are you a physician practising in the UK and prescribing treatments? We invite you to learn more about our targeted studies.

Locations United Kingdom IQVIA Medical Studies Ad Hoc studies in under 60 minutes

Ad Hoc studies in under 60 minutes

These studies aim to explore various pathologies and their treatments, as well as the use, perception and possible future applications of specific treatments, services and health products.

They will be offered to you based on your primary medical speciality.

The pathologies studied include, among others: different types of cancer (solid and liquid tumours), autoimmune diseases, depression, respiratory, rheumatological, dermatological, cardiological, neurological, endocrinological conditions.

Most medical specialities are involved.

The duration of each study typically ranges from 10 to 60 minutes.

The Different Types of Studies Offered

Quantitative studies

One-off studies : These focus on the treatment of a specific pathology or on perceptions related to it.
Tracking studies (Trackers) : These are conducted at regular intervals to monitor the progression of treated patients, treatment choices, and behaviours (e.g. treatment adherence, prescribing habits and patient follow-up practices).

The questionnaires remain consistent over time, with intervals typically being monthly, quarterly, or annually.

Examples: Autoimmune diseases treated with biotherapies, multiple myeloma, non-small cell lung cancer, prostate cancer.

Qualitative studies

These studies are generally conducted online, by telephone, or via video conference.

Focus groups: Group discussions among physicians on specific topics, such as the treatment of non-alcoholic fatty liver disease or childhood myopia.
Individual interview: One-on-one discussions with a moderator focusing on a particular pathology and its current or potential future treatments.

PASS Studies (Post-Authorization Safety Studies)

These studies aim to identify, characterise or quantify a safety risk for patients, confirm the safety profile of an authorised drug, or assess the effectiveness of risk management measures.

They provide a comprehensive overview of a drug's safety once it has been placed on the market.

Nominative Studies KOL (Key Opinion Leader)

These studies aim to identify influential experts in specific medical or scientific fields in order to understand their impact and reach within the medical community.

Regulatory Framework

At IQVIA, research studies are strictly governed by multiple regulations to protect participants and ensure the integrity of the data collected.

This framework is essential to guarantee transparency, legal compliance, and ethical standards, while also supporting innovation and the development of new therapies.

Your data is anonymised and processed in compliance with the GDPR. No identifiable patient information is collected.

Before each study you will be asked to provide:

Your consent to participate in the study. Informed consent is essential to ensure that participants fully understand the study's objectives, methods, potential risks and benefits. It guarantees that participation is both voluntary and informed.

Key steps to participate in targeted studies

Invitation

As soon as a study becomes available that matches your speciality, you receive an invitation by email. This invitation will include the study topic, its duration, the associated compensation amount, and the closing date.

Platform access

Most of our studies can be completed online via our platform. You can log in using your personal access codes, allowing you to view available studies, your participation history, and relevant medical content.

Pre-screening questions

These questions determine whether you:

Meet the study criteria and research objectives.
Possess the necessary characteristics to contribute meaningfully, thereby ensuring the integrity and validity of the data collected.

Main questionnaire

It may include patient cases, in which all data is fully anonymised.

Compensation

You will receive a financial compensation for each participation. You can choose from the following options:

Payment to the IQVIA Healthcare Research Partner Program Visa® Prepaid Card.
Amazon Gift Cards

Join us!

Get Involved

Your contribution is essential to improving healthcare practices. Take the opportunity to participate in innovative studies that can lead to more effective treatments for patients.

Diversify

Participating in our studies offers you the opportunity to diversify your professional activities, take a break from routine, and reflect on the reasoning behind your clinical decisions.

Take action

Questions?

For more information on the studies, we invite you to fill out our form.

E-Mail: global-pmr-en@iqvia.com
Freephone UK: 0800 0323 027